Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Steroids No Help In Pediatric Biliary Atresia

November 8, 2013 By Ed Susman

High-dose steroids following initial surgery for pediatric biliary atresia do not help prevent the need for liver transplantation, researchers reported here.

Of the 70 children assigned to receive corticosteroids following hepatoportoenterostomy, 58.6% achieved a total bilirubin of less than 1.5 mg/dL at 6 months with his or her native liver, compared with 48.6% of the 70 children who were treated with placebo, for an adjusted relative risk of 1.14 in both the intention-to-treat analysis (95% CI 0.83-1.57, P=0.43) and in the per-protocol analysis (95% CI 0.81-1.61, P=0.44), said Jorge Bezerra, MD, of the University of Cincinnati Children’s Hospital.

In the secondary endpoint, survival with the native liver at 24 months was 58.7% with steroids and 59.4% with placebo (P=0.99), Bezerra said at the annual meeting of the American Association for the Study of Liver Diseases.

“Therefore, the addition of high-dose steroids as an adjuvant treatment after hepatoportoenterostomy cannot be recommended,” he said in his plenary presentation.

Bezerra noted that biliary atresia, a rapidly fibrosing cholangiopathy that obstructs the extrahepatic bile duct, is the most common cause of end-stage cirrhosis in children and the most frequent indication for pediatric liver transplantation. The primary treatment is the surgical excision of the biliary remnant followed by roux-en-y hepatoportoenterostomy, which has a reported success rate for restoring bile drainage of about 50% in the U.S.

“Despite treatment,” Bezerra said, “the intrahepatic cholangiopathy progresses and more than 70% of patients ultimately require liver transplantation. Therefore, there is a need for adjunct therapies to improve survival with the native liver.”

Over the years groups in the United States, and notably in Japan, have suggested use of corticosteroids as an adjuvant therapy based on their anti-inflammatory effects, he explained. Several studies have reported mixed results.

Hence, Bezerra said, “we conducted the Steroids in Biliary Atresia Randomized Trial (START) as a double-blind and placebo-controlled study, designed to determine whether the treatment with high-dose steroids after portoenterostomy is superior to the surgical procedure alone.”

Continue reading…

Related Articles Read More >

Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
Wire mesh that has captured a blood clot
How an Embotrap stent retriever thrombectomy treats ischemic strokes
A team of doctors use the Hemafuse device to collect and filter a surgery patient's blood
Autotranfusion device maker ships units to Ukraine
A close-up photo of a human eye
Proposed 2023 Medicare Physician Fee Schedule could have a big impact on glaucoma surgeries

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech